Kenvue Inc. (KVUE) To Go Ex-Dividend on August 12th

Kenvue Inc. (NYSE:KVUE) declared a quarterly dividend on Wednesday, July 29th. Shareholders of record on Wednesday, August 12th will be given a dividend of 0.21 per share on Wednesday, August 26th. This represents a c) dividend on an annualized basis and a yield of 4.4%. The ex-dividend date is Wednesday, August 12th. This is a 1.2% increase from Kenvue’s previous quarterly dividend of $0.21.

Kenvue has a payout ratio of 68.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Kenvue to earn $1.23 per share next year, which means the company should continue to be able to cover its $0.83 annual dividend with an expected future payout ratio of 67.5%.

Kenvue Stock Down 2.6%

KVUE stock opened at $19.27 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.98 and a quick ratio of 0.70. Kenvue has a 1-year low of $14.02 and a 1-year high of $22.28. The firm has a fifty day moving average price of $18.56 and a two-hundred day moving average price of $18.00. The firm has a market cap of $37.00 billion, a price-to-earnings ratio of 22.67, a PEG ratio of 1.50 and a beta of 0.47.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, May 7th. The company reported $0.32 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a net margin of 10.61% and a return on equity of 20.81%. The company had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $3.84 billion. During the same period last year, the firm posted $0.24 EPS. The company’s revenue for the quarter was up 4.5% on a year-over-year basis. Research analysts predict that Kenvue will post 1.16 EPS for the current year.

Kenvue Company Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.